Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Prostate. 2012 Nov 28;73(7):754–762. doi: 10.1002/pros.22619

TABLE I.

Survival (vs. Control; Cox Proportional Hazards)

Study group Hazard ratio (95% CI) P-value
LAPC-4 study
 RV50 1.53 (1.03–2.27) 0.04
 RV100 1.22 (0.83–1.81) 0.32
LNCaP study
 RV50 0.77 (0.51–1.17) 0.22